cAMP-dependent protein kinase regulatory subunit type IIbeta: active site mutations define an isoform-specific network for allosteric signaling by cAMP
- PMID: 14625280
- DOI: 10.1074/jbc.M310804200
cAMP-dependent protein kinase regulatory subunit type IIbeta: active site mutations define an isoform-specific network for allosteric signaling by cAMP
Abstract
cAMP-dependent protein kinase (cAPK) contains a regulatory (R) subunit dimer bound to two catalytic (C) subunits. Each R monomer contains two cAMP-binding domains, designated A and B. The sequential binding of two cAMPs releases active C. We describe here the properties of RIIbeta and two mutant RIIbeta subunits, engineered by converting a conserved Arg to Lys in each cAMP-binding domain thereby yielding a protein that contains one intact, high affinity cAMP-binding site and one defective site. Structure and function were characterized by circular dichroism, steady-state fluorescence, surface plasmon resonance and holoenzyme activation assays. The Ka for RIIbeta is 610 nM, which is 10-fold greater than its Kd(cAMP) and significantly higher than for RIalpha and RIIalpha. The Arg mutant proteins demonstrate that the conserved Arg is important for both cAMP binding and organization of each domain and that binding to domain A is required for activation. The Ka of the A domain mutant protein is 21-fold greater than that of wild-type and the Kd(cAMP) is increased 7-fold, confirming that cAMP must bind to the mutated site to initiate activation. The domain B mutant Ka is 2-fold less than its Kd(cAMP), demonstrating that, unlike RIalpha, cAMP can access the A site even when the B site is empty. Removal of the B domain yields a Ka identical to the Kd(cAMP) of full-length RIIbeta, indicating that the B domain inhibits holoenzyme activation for RIIbeta. In RIalpha, removal of the B domain generates a protein that is more difficult to activate than the wild-type protein.
Similar articles
-
Dissecting interdomain communication within cAPK regulatory subunit type IIbeta using enhanced amide hydrogen/deuterium exchange mass spectrometry (DXMS).Protein Sci. 2003 Sep;12(9):1980-90. doi: 10.1110/ps.03166903. Protein Sci. 2003. PMID: 12930997 Free PMC article.
-
Active site mutations define the pathway for the cooperative activation of cAMP-dependent protein kinase.Biochemistry. 1996 Mar 5;35(9):2934-42. doi: 10.1021/bi951647c. Biochemistry. 1996. PMID: 8608131
-
The roles of the RIIβ linker and N-terminal cyclic nucleotide-binding domain in determining the unique structures of the type IIβ protein kinase A: a small angle x-ray and neutron scattering study.J Biol Chem. 2014 Oct 10;289(41):28505-12. doi: 10.1074/jbc.M114.584177. Epub 2014 Aug 11. J Biol Chem. 2014. PMID: 25112875 Free PMC article.
-
Structure, function, and regulation of human cAMP-dependent protein kinases.Adv Second Messenger Phosphoprotein Res. 1997;31:191-204. doi: 10.1016/s1040-7952(97)80019-5. Adv Second Messenger Phosphoprotein Res. 1997. PMID: 9344252 Review.
-
Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design.Biochim Biophys Acta. 2008 Jan;1784(1):16-26. doi: 10.1016/j.bbapap.2007.10.002. Epub 2007 Oct 12. Biochim Biophys Acta. 2008. PMID: 17996741 Free PMC article. Review.
Cited by
-
The role of type 4 phosphodiesterases in generating microdomains of cAMP: large scale stochastic simulations.PLoS One. 2010 Jul 22;5(7):e11725. doi: 10.1371/journal.pone.0011725. PLoS One. 2010. PMID: 20661441 Free PMC article.
-
Two PKA RIα holoenzyme states define ATP as an isoform-specific orthosteric inhibitor that competes with the allosteric activator, cAMP.Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16347-16356. doi: 10.1073/pnas.1906036116. Epub 2019 Jul 30. Proc Natl Acad Sci U S A. 2019. PMID: 31363049 Free PMC article.
-
Therapeutic strategies for anchored kinases and phosphatases: exploiting short linear motifs and intrinsic disorder.Front Pharmacol. 2015 Jul 28;6:158. doi: 10.3389/fphar.2015.00158. eCollection 2015. Front Pharmacol. 2015. PMID: 26283967 Free PMC article. Review.
-
Localization and quaternary structure of the PKA RIβ holoenzyme.Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12443-8. doi: 10.1073/pnas.1209538109. Epub 2012 Jul 13. Proc Natl Acad Sci U S A. 2012. PMID: 22797896 Free PMC article.
-
Transient calcium and dopamine increase PKA activity and DARPP-32 phosphorylation.PLoS Comput Biol. 2006 Sep 8;2(9):e119. doi: 10.1371/journal.pcbi.0020119. PLoS Comput Biol. 2006. PMID: 16965177 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
